References
Alfaidy, N, Gupta, S, DeMarco, C, Caniggia, I, & Challis, JRG. (2002). Oxygen regulation of placental 11β-hydroxysteroid dehydrogenase 2: physiological and pathological implications. The Journal of Clinical Endocrinology & Metabolism, 87 (10), 4797-4805.
Bridgman, J. (1948). A morphological study of the development of the placenta of the rat; an outline of the development of the placenta of the white rat. J Morphol, 83 (1), 61-85. doi: 10.1002/jmor.1050830104
Brown, R. W., Chapman, K. E., Kotelevtsev, Y., Yau, J. L., Lindsay, R. S., Brett, L.et al. (1996). Cloning and production of antisera to human placental 11 beta-hydroxysteroid dehydrogenase type 2. Biochem J, 313 ( Pt 3) , 1007-1017. doi: 10.1042/bj3131007
Burton, P.J., & Waddell, B.J. (1999). Dual function of 11β-hydroxysteroid dehydrogenase in placenta: modulating placental glucocorticoid passage and local steroid action.Biology of Reproduction, 60 (2), 234-240.
Causevic, M., & Mohaupt, M. (2007). 11β-Hydroxysteroid dehydrogenase type 2 in pregnancy and preeclampsia.Molecular aspects of medicine, 28 (2), 220-226.
Chen, H. C. (2005). Boyden chamber assay. Methods in Molecular Biolology, 294 , 15-22. doi: 10.1385/1-59259-860-9:015
Cotechini, T., Komisarenko, M., Sperou, A., Macdonald-Goodfellow, S., Adams, M. A., & Graham, C.H. (2014). Inflammation in rat pregnancy inhibits spiral artery remodeling leading to fetal growth restriction and features of preeclampsia.Journal of Experimental Medicine, 211 (1), 165-179.
Cottrell, E. C., Seckl, J. R., Holmes, M. C., & Wyrwoll, C. S. (2014). Foetal and placental 11beta-HSD2: a hub for developmental programming. Acta Physiologica (Oxf), 210 (2), 288-295. doi: 10.1111/apha.12187
Duax, W.L, Ghosh, D., & Pletnev, V. (2000). Steroid dehydrogenase structures, mechanism of action, and disease. Vitamin & Hormones 58,121-148
Fahlbusch,F.B., Ruebner, M., Rascher, W., & Rauh, M. (2013). Combined quantification of corticotropin-releasing hormone, cortisol-to-cortisone ratio and progesterone by liquid chromatography–Tandem mass spectrometry in placental tissue. Steroids, 78 (9), 888-895.
Fahlbusch, F B, Heussner, K, Schmid, M, Schild, R, Ruebner, M, Huebner, H.et al. (2015) Measurement of amniotic fluid steroids of midgestation via LC–MS/MS. The Journal of steroid biochemistry and molecular biology, 152 , 155-160.
Fowden, A.L, & Forhead, A.J. (2015). Glucocorticoids as regulatory signals during intrauterine development.Experimental physiology, 100 (12), 1477-1487.
Fraser, T. B, Turner, S.W, Mangos, GJ, Ludbrook, J, & Whitworth, JA. (2001). Comparison of telemetric and tail‐cuff blood pressure monitoring in adrenocorticotrophic hormone‐treated rats. Clinical and Experimental Pharmacology and Physiology, 28 (10), 831-835.
Hofmann M, Pollow K, Bahlmann F, Casper F, Steiner E. & Brockerhoff , P. (2001) 11 beta-hydroxysteroid dehydrogenase (11 beta-HSD-II) activity in human placenta: its relationship to placental weight and birth weight and its possible role in hypertension. Journal of Perinatal Medicine, 29(1):23-30. doi: 10.1515/JPM.2001.003.
He, P., Chen, Z., Sun, Q., Li, Y., Gu, H., & Ni, X. (2014). Reduced expression of 11beta-hydroxysteroid dehydrogenase type 2 in preeclamptic placentas is associated with decreased PPARgamma but increased PPARalpha expression.Endocrinology, 155 (1), 299-309. doi: 10.1210/en.2013-1350
Hodel, M., Blank, P. R., Marty, P., & Lapaire, O. (2019). sFlt-1/PlGF Ratio as a Predictive Marker in Women with Suspected Preeclampsia: An Economic Evaluation from a Swiss Perspective. Disease Markers, 2019 , 4096847. doi: 10.1155/2019/4096847
Hu, T., Wang, G., Zhu, Z., Huang, Y., Gu, H., & Ni, X. (2015). Increased ADAM10 expression in preeclamptic placentas is associated with decreased expression of hydrogen sulfide production enzymes. Placenta, 36 (8), 947-950. doi: 10.1016/j.placenta.2015.05.007
Hung, T. H., Chen, S. F., Hsieh, C. C., Hsu, J. J., Li, M. J., Yeh, Y. L.,et.al. (2008). Tumor necrosis factor-alpha converting enzyme in the human placenta throughout gestation. Reproductive Science, 15 (2), 195-209. doi: 10.1177/1933719107310709
Hunter, R.W, & Bailey, M.A. (2015). Glucocorticoids and 11β-hydroxysteroid dehydrogenases: mechanisms for hypertension. Current opinion in pharmacology, 21 , 105-114.
Jones JC, Rustagi S, Dempsey PJ. (2016) ADAM Proteases and Gastrointestinal Function. Annual Review of Physiology. 78:243-76.
Kisanga, EP, Tang, Z, Guller, S & Whirledge, S. (2018). Glucocorticoid signaling regulates cell invasion and migration in the human first‐trimester trophoblast cell line Sw. 71.American Journal of Reproductive Immunology, 80 (1), e12974.
Li, XQ, Zhu, P, Myatt, Leslie, & Sun, K. (2014). Roles of glucocorticoids in human parturition: a controversial fact? Placenta, 35 (5), 291-296.
Li, Z., Zhang, Y., Ying Ma, J., Kapoun, A. M., Shao, Q., Kerr, I.,et al. (2007). Recombinant vascular endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsia. Hypertension, 50 (4), 686-692. doi: 10.1161/hypertensionaha.107.092098
Lindsay, R.S, Lindsay, R.M, Edwards, C.R. & Seckl, J.R. (1996). Inhibition of 11β-hydroxysteroid dehydrogenase in pregnant rats and the programming of blood pressure in the offspring. Hypertension, 27 (6), 1200-1204.
Ma, R., Gu, Y., Groome, L. J., & Wang, Y. (2011). ADAM17 regulates TNFalpha production by placental trophoblasts. Placenta, 32 (12), 975-980. doi: 10.1016/j.placenta.2011.09.015
Mandl, M, Ghaffari-Tabrizi, N, Haas, J, Nohammer, G, & Desoye, G. (2006). Differential glucocorticoid effects on proliferation and invasion of human trophoblast cell lines.Reproduction, 132 (1), 159-167.
Mirazi, N., Alfaidy, N., Martin, R., & Challis, J.R.G. (2004). Effects of dexamethasone and sulfasalazine on prostaglandin E2 output by human placental cells in vitro. Journal of the Society for Gynecologic Investigation, 11 (1), 22-26.
Murphy, K. E., Willan, A. R., Hannah, M. E., Ohlsson, A., Kelly, E. N., Matthews, S. G.,et.al. (2012). Effect of antenatal corticosteroids on fetal growth and gestational age at birth. Obstetrics and Gynecology, 119 (5), 917-923. doi: 10.1097/AOG.0b013e31825189dc
Patel, F.A, Sun, K.,& Challis, J.R.G. (1999). Local modulation by 11β-hydroxysteroid dehydrogenase of glucocorticoid effects on the activity of 15-hydroxyprostaglandin dehydrogenase in human chorion and placental trophoblast cells.The Journal of Clinical Endocrinology & Metabolism, 84 (2), 395-400.
Pavek, P, Cerveny, L, Svecova, L, Brysch, M, Libra, A, Vrzal, R, et al. (2007). Examination of Glucocorticoid receptor α-mediated transcriptional regulation of P-glycoprotein, CYP3A4, and CYP2C9 genes in placental trophoblast cell lines. Placenta, 28 (10), 1004-1011.
Peng, B, Zhu, H, Klausen, C., Ma, L., Wang, Y.-L., & Leung, P. C.K. (2016). GnRH regulates trophoblast invasion via RUNX2-mediated MMP2/9 expression. Mhr: Basic science of reproductive medicine, 22 (2), 119-129.
Renaud, S.J, Cotechini, T., Quirt, J.S, Macdonald-Goodfellow, S. K, Othman, M., & Graham, C. H. (2011). Spontaneous pregnancy loss mediated by abnormal maternal inflammation in rats is linked to deficient uteroplacental perfusion. The Journal of Immunology, 186 (3), 1799-1808.
Roberts, JM, & Cooper, D. W. (2001). Pathogenesis and genetics of pre-eclampsia. The Lancet, 357 (9249), 53-56.
Saleh, L., Samantar, R., Garrelds, I. M., van den Meiracker, A. H., Visser, W., & Danser, A. H. J. (2017). Low Soluble Fms-Like Tyrosine Kinase-1, Endoglin, and Endothelin-1 Levels in Women With Confirmed or Suspected Preeclampsia Using Proton Pump Inhibitors. Hypertension, 70 (3), 594-600. doi: 10.1161/hypertensionaha.117.09741
Saleh, L., Verdonk, K., Jan Danser, A. H., Steegers, E. A., Russcher, H., van den Meiracker, A. H., & Visser, W. (2016). The sFlt-1/PlGF ratio associates with prolongation and adverse outcome of pregnancy in women with (suspected) preeclampsia: analysis of a high-risk cohort. European Journal of Obstetrics, Gynecology and Reproductive Biology, 199 , 121-126. doi: 10.1016/j.ejogrb.2016.02.013
Sanna, PP, Kawamura, T, Chen, J, Koob, GF, Roberts, AJ, Vendruscolo, LF, & Repunte-Canonigo, V. (2016). 11β-hydroxysteroid dehydrogenase inhibition as a new potential therapeutic target for alcohol abuse. Translational psychiatry, 6 (3), e760-e760.
Schoof, E, Girstl, M, Frobenius, W, Kirschbaum, M, Dorr, HG, Rascher, W, & Dotsch, J. (2001). Decreased gene expression of 11β-hydroxysteroid dehydrogenase type 2 and 15-hydroxyprostaglandin dehydrogenase in human placenta of patients with preeclampsia. The Journal of Clinical Endocrinology & Metabolism, 86 (3), 1313-1317.
Seki, H. (2014). Balance of antiangiogenic and angiogenic factors in the context of the etiology of preeclampsia. Acta obstetricia et gynecologica Scandinavica, 93 (10), 959-964.
Sibai, B., Dekker, G., & Kupferminc, M. (2005). Pre-eclampsia. Lancet, 365 (9461), 785-799. doi: 10.1016/s0140-6736(05)17987-2
Stewart, PM, Wallace, AM, Atherden, SM, Shearing, CH, & Edwards, CRW. (1990). Mineralocorticoid activity of carbenoxolone: contrasting effects of carbenoxolone and liquorice on 11 β-hydroxysteroid dehydrogenase activity in man. Clinical Science, 78 (1), 49-54.
Strevens, H., Wide‐Swensson, D., Grubb, A., Hansen, A., Horn, T., Ingemarsson, I. et. al. (2003). Serum cystatin C reflects glomerular endotheliosis in normal, hypertensive and pre‐eclamptic pregnancies. BJOG: An International Journal of Obstetrics & Gynaecology, 110 (9), 825-830.
Szpera-Gozdziewicz, A. & Breborowicz, G.H. (2014). Endothelial dysfunction in the pathogenesis of pre-eclampsia. Front Biosci (Landmark Ed), 19 (1), 734.
Welberg, L. A., Seckl, J. R., & Holmes, M. C. (2000). Inhibition of 11beta-hydroxysteroid dehydrogenase, the foeto-placental barrier to maternal glucocorticoids, permanently programs amygdala GR mRNA expression and anxiety-like behaviour in the offspring. European Journal of Neuroscience, 12 (3), 1047-1054. doi: 10.1046/j.1460-9568.2000.00958.x
Yang, Y., Wang, Y., Zeng, X., Ma, X. J., Zhao, Y., Qiao, J. et. al. (2012). Self-control of HGF regulation on human trophoblast cell invasion via enhancing c-Met receptor shedding by ADAM10 and ADAM17. Journal of Clinical Endocrinology and Metabolism, 97 (8), E1390-1401. doi: 10.1210/jc.2012-1150
Zannas, A.S, & Chrousos, G. P. (2015). Glucocorticoid signaling drives epigenetic and transcription factors to induce key regulators of human parturition. Sci. Signal., 8 (400), fs19-fs19.
Zeisler, H., Llurba, E., Chantraine, F., Vatish, M., Staff, A.C, Sennström, M.,et al. (2016). Soluble fms-like tyrosine kinase-1-to-placental growth factor ratio and time to delivery in women with suspected preeclampsia. Obstetrics & Gynecology, 128 (2), 261-269.
Zha, Y. P., Wang, Y. K., Deng, Y., Zhang, R. W., Tan, X., Yuan, W. J., et al. (2013). Exercise training lowers the enhanced tonically active glutamatergic input to the rostral ventrolateral medulla in hypertensive rats. CNS Neurosci Ther, 19 (4), 244-251. doi: 10.1111/cns.12065
Zhang, B., Tan, L., Yu, Y., Wang, B., Chen, Z., Han, J., et al. (2018). Placenta-specific drug delivery by trophoblast-targeted nanoparticles in mice. Theranostics, 8 (10), 2765-2781. doi: 10.7150/thno.22904
Zhang, H., Hou, L., Li, C. M., & Zhang, W. Y. (2013). The chemokine CXCL6 restricts human trophoblast cell migration and invasion by suppressing MMP-2 activity in the first trimester. Hum Reprod, 28 (9), 2350-2362. doi: 10.1093/humrep/det258
Zhao, S., Gu, Y., Fan, R., Groome, L. J., Cooper, D., & Wang, Y. (2010). Proteases and sFlt-1 release in the human placenta. Placenta, 31 (6), 512-518. doi: 10.1016/j.placenta.2010.03.014
Zunke,F.,Rose-John, S (2017). The Shedding Protease ADAM17: Physiology and Pathophysiology. Biochimica et biophysica acta. Molecular cell research. 1864 (11 Pt B), 2059-2070